Fresenius Kabi launches generic Arsenic Trioxide Injection in US to enhance oncology treatment options
German health care company Fresenius Kabi has announced the US launch of its new generic drug, Arsenic Trioxide Injection. This product, a generic version of Teva Pharmaceutical Industries’ leukemia treatment Trisenox, is set to offer a more affordable option for patients battling acute promyelocytic leukemia (APL). Arsenic Trioxide Injection for Acute Promyelocytic Leukemia Arsenic Trioxide […]